Complete Genomics, Inc. (GNOM) Posts Q2 EPS Loss of $0.56, Revenue Falls Below Expectations

Complete Genomics, Inc. (NASDAQ: GNOM) reported Q2 EPS of ($0.56), $0.07 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $7.68 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c